Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Int J Gynecol Pathol. 2022 Aug 31;42(3):259–269. doi: 10.1097/PGP.0000000000000921

Figure 8.

Figure 8.

Analysis of progression-free survival (PFS) between cervical adenosquamous carcinomas (ASCs) versus Human papillomavirus (HPV)-associated ECAs (HPVAs); ASCs versus invasive stratified mucin-producing carcinomas (iSMCs) (pure and with components); iSMCs pure versus iSMCs with components.